Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Introduction to Protein Folding and Misfolding
-
1. Protein folding and misfolding: from theory to therapy
- Prof. Christopher Dobson
- Stability and Kinetics of Protein Folding
-
2. Mechanisms of protein folding reactions
- Prof. Thomas Kiefhaber
- Protein Folding Theory
-
3. Mapping disordered proteins with single-molecule FRET
- Dr. Hagen Hofmann
- Protein Folding Simulations
-
4. Protein folding
- Prof. Eugene Shakhnovich
-
5. Simulating protein folding with full atomistic detail
- Prof. Vijay Pande
-
6. Molecular dynamics simulations of protein dynamics, unfolding and misfolding
- Prof. Valerie Daggett
- Protein Folding Inside the Cell: Chaperones
-
7. Protein folding Inside the cell: macromolecular crowding and protein aggregation
- Prof. Emeritus R. John Ellis
-
8. Chaperone mechanisms in cellular protein folding
- Prof. Dr. F. Ulrich Hartl
-
9. Quality control of proteins mislocalized to the cytosol
- Dr. Ramanujan Hegde
- Protein Misfolding and Disease
- Protein Design
-
11. Designing proteins with life sustaining activities 1
- Prof. Michael Hecht
-
12. Designing proteins with life sustaining activities 2
- Prof. Michael Hecht
-
13. Folding and design of helical repeat proteins
- Prof. Lynne Regan
-
14. Design and engineering of zinc-finger domains
- Prof. Jacqui Matthews
-
15. Prediction and design of protein structures and interactions
- Prof. David Baker
- Amyloid Fibrils: Structure, Formation and Nanotechnology
-
16. Amyloid fibrils as functional nanomaterials
- Prof. Juliet Gerrard
-
17. Functional amyloid fibrils from fungi and viruses
- Prof. Margaret Sunde
- Intrinsically disordered Proteins
-
18. Fuzzy protein theory for disordered proteins
- Prof. Monika Fuxreiter
- Intersection of RNA, translation and protein aggregation.
-
19. Expanding roles of RNA-binding proteins in neurodegenerative diseases
- Prof. Aaron D. Gitler
- Proteostasis
-
20. Adapting proteostasis to ameliorate aggregation-associated amyloid diseases
- Dr. Jeffery W. Kelly
- Archived Lectures *These may not cover the latest advances in the field
-
21. Amyloidosis: disease caused by amyloid
- Prof. Mark Pepys
-
22. Protein folding and dynamics from single molecule spectroscopy
- Prof. Dr. Benjamin Schuler
-
23. Prion diseases
- Prof. Fred Cohen
-
25. Titin I27: a protein with a complex folding landscape
- Dr. Jane Clarke
-
26. Novel proteins from designed combinatorial libraries
- Prof. Michael Hecht
-
28. The sequence determinants of amyloid fibril formation
- Prof. Fabrizio Chiti
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Protein folding and misfolding
- Amyloid fibrils: features
- Finding exciting applications for amyloid fibrils
- Graphene-amyloid composites
- Amyloid aerogel
- Amyloid fibrils from waste materials
- Amyloid fibril production
- Identification of β-sheet structures
- Haemoglobin
- Eye lenses: a source of crystallin proteins
- “Standard conditions”
- Fibrils from crystallin proteins
- Tweaking the conditions, alters the morphology
- Assembly of bigger structures
- Controlling morphology (insulin)
- Controlling length (insulin)
- Applications like a carbon nanotube
- A nanoscaffold for immobilised enzymes
- Attachment of enzymes to fibrils
- Active OPH immobilised onto the nanoscaffold
- Amyloid fibrils have OPH activity
- Covalent crosslinking may not be essential
- Amyloid fibrils + OPH, glutaraldehyde
- Thermostability of OPH is improved at 45°C
- Nanofibrils, with quantum dots
- Dual functionalisation
- Towards useful materials
- Proof of concept: amyloid fibrils in PVOH films
- Immobilisation of glucose oxidase
- Glucose oxidase remains active on nanoscaffold
- Fibrils as nanowires?
- Glucose oxidase
- Glucose sensing experiment
- Glucose sensing
- Stability to proteases
- Stability to solvents
- Cytotoxicity: Hec1a cell lines
- Conclusions
- Acknowledgements
Topics Covered
- Generating useful materials from proteins
- Amyloid fibrils from waste materials in a commercially scalable process
- Nanoscaffolds for enzyme immobilisation
- Templates for nanowires and biosensors
Talk Citation
Gerrard, J. (2017, December 31). Amyloid fibrils as functional nanomaterials [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 22, 2024, from https://doi.org/10.69645/HWLS5169.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Juliet Gerrard has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Juliet Gerrard,
and I'm from the University of Auckland.
And today I'd like to tell you about amyloid fibrils as functional Nanomaterials.
You've heard something about amyloid fibrils
from other lectures in this series, but today,
rather than focus on their role in the body or in disease,
I'll be talking you through how you might think of them as
a useful material to use outside the body for a whole range of application.
0:30
So, as an outline of my talk,
I'll start up just to orient you and take you through what amyloid fibrils
are and how and why we want to make them.
And I'll just give you a quick taste of the sorts of
applications that are being developed for these materials worldwide.
Then I'll focus on our efforts in my lab to generate
amyloid fibrils from readily available sustainable sources.
And I'll give you a couple of examples of applications that we've worked on in
my lab that really exemplify the strengths of these materials.
First of all as a nanoscaffold for enzyme immobilisation and
then as a template for nanowires and biosensors.
1:11
So, in this slide, I've given you a very simple picture of
protein folding and misfolding inside and outside the cell.
So, if you start on the left of the slide that's where you can imagine the protein being
synthesized on the ribosome and the polypeptide chain leaves the ribosome unfolded,
but very quickly starts to fold into a variety of different folded forms.
Moving down the diagram,
you can see the intermediate folded states.
And the states that coalesce into the native form,
which of course could be oligomeric protein in vivo or it could be a fiber.
In the laboratory, we spend a lot of time trying to make sure that the protein stays
in that native form or folds into it if we're expressing it recombinantly.
And we try to avoid the disordered aggregates
that you can see forming on the periphery of the slide.
When we tried to make an amyloid fibril,
what we do is try to slightly destabilize the native form to get back to
the intermediate folded state and form
the prefibrillar species that go on to form the amyloid fibrils.
Beyond this, if we want the amyloid fibrils to be used outside the cell,
we would like them to form bigger structures.
I've emphasized this point.
In many ways this is more of an art than a science,
as we screen lots of different conditions to try to
find the right ones to do hierarchical assembly.
So, the ideal process would be to start with a native protein or an unfolded protein,
but it tends to be easier from the native form,
destabilize it slightly, and managed to capture
the amyloid fibrils in
solution conditions that are predisposed to form those biggest structures.